Search results for "Lua"

showing 10 items of 3286 documents

The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

2009

After more than two decades of research into phosphodiesterase 4 (PDE4) inhibitors, roflumilast (3-cyclopropylmethoxy-4-difluoromethoxy-N-[3,5-di-chloropyrid-4-yl]-benzamide) may become the first agent in this class to be approved for patient treatment worldwide. Within the PDE family of 11 known isoenzymes, roflumilast is selective for PDE4, showing balanced selectivity for subtypes A-D, and is of high subnanomolar potency. The active principle of roflumilast in man is its dichloropyridyl N-oxide metabolite, which has similar potency as a PDE4 inhibitor as the parent compound. The long half-life and high potency of this metabolite allows for once-daily, oral administration of a single, 500…

CyclopropanesPulmonary and Respiratory MedicinePhosphodiesterase Inhibitorsmedicine.drug_classDrug Evaluation PreclinicalAdministration OralAminopyridinesInflammationPharmacologyPulmonary Disease Chronic ObstructiveCOPD; Inflammation; Oral therapy; Phosphodiesterase 4; Preclinical pharmacology; RoflumilastBronchodilatormedicineAnimalsHumansCOPDPharmacology (medical)RoflumilastPhosphodiesterase 4InflammationCOPDLungOral therapybusiness.industryAnti-Inflammatory Agents Non-SteroidalBiochemistry (medical)medicine.diseasePulmonary hypertensionObstructive lung diseasemedicine.anatomical_structureTolerabilityBenzamidesImmunologyPhosphodiesterase 4 InhibitorsPreclinical pharmacologymedicine.symptombusinessRoflumilastmedicine.drug
researchProduct

Daratumumab for the Treatment of Multiple Myeloma

2018

This mini-review will summarize the present state of development of the CD38 antibody daratumumab for the treatment of multiple myeloma.

Cytotoxicity Immunologic0301 basic medicineOncologylcsh:Immunologic diseases. Allergymedicine.medical_specialtyAdenosineTreatment outcomeImmunologyDrug Evaluation PreclinicalComplementAntineoplastic AgentsMyelomaimmunomodulationImmunomodulation03 medical and health sciences0302 clinical medicineAntibodies monoclonalimmune system diseasesInternal medicineDaratumumabhemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsmedicineAnimalsHumansImmunology and AllergycomplementMultiple myelomaNeonatal Fc-receptorsClinical Trials as Topicbusiness.industryAntibody-Dependent Cell CytotoxicityAntibodies MonoclonalDaratumumabmedicine.diseasedaratumumabTrogocytosis3. Good healthTreatment Outcome030104 developmental biologymyelomaadenosine030220 oncology & carcinogenesisAntibody-dependent cell cytotoxicityMultiple Myelomabusinesslcsh:RC581-607CD38Frontiers in Immunology
researchProduct

Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro

2012

Maintaining graft versus leukemia (GvL) and antivirus responses of cytotoxic T cells (CTLs) while suppressing graft-versus-host disease (GvHD) remains a challenge after allogeneic bone marrow transplantation. Clinical observations indicate that combining glucocorticoids with multi-tyrosine-kinase inhibitors could be a successful therapeutic approach. We and others have shown that the BCR-ABL/SRC kinase inhibitor dasatinib may enhance or suppress T cells in vitro. In this report, we evaluated combination effects of dasatinib and dexamethasone on CD3 + and virus-specific CD8 + T cells directly ex vivo and on antigen-specific leukemia-reactive and alloreactive CD8 + T cell clones. Functional o…

Cytotoxicity ImmunologicHerpesvirus 4 HumanCancer ResearchNaive T cellT cellDasatinibDrug Evaluation PreclinicalReceptors Antigen T-CellCytomegalovirusApoptosisT-Cell Antigen Receptor SpecificityBiologyLymphocyte ActivationCell DegranulationDexamethasoneAntigenHLA AntigensT-Lymphocyte SubsetsGeneticsmedicineHumansCytotoxic T cellAntigens ViralProtein Kinase InhibitorsMolecular BiologyCells CulturedDegranulationDrug SynergismT-Lymphocytes Helper-InducerCell BiologyHematologyDasatinibThiazolesPyrimidinesmedicine.anatomical_structureImmunologyCancer researchCytokinesK562 CellsMemory T cellCell DivisionCD8Signal TransductionT-Lymphocytes Cytotoxicmedicine.drugExperimental Hematology
researchProduct

P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.

2008

Monoclonal antibodies (mAbs), successfully adopted in the treatment of several haematological malignancies, have proved almost ineffective in multiple myeloma (MM), because of the lack of an appropriate antigen for targeting and killing MM cells. Here, we demonstrate that PSGL1, the major ligand of P-Selectin, a marker of plasmacytic differentiation expressed at high levels on normal and neoplastic plasma cells, may represent a novel target for mAb-mediated MM immunotherapy. The primary effectors of mAb-induced cell-death, complement-mediated lysis (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC), were investigated using U266B1 and LP1 cell-lines as models. Along with immunolo…

Cytotoxicity ImmunologicMembrane Glycoproteinsmieloma multiplo; ab therapy; PSGL-1ab therapyAntibody-Dependent Cell CytotoxicityDrug Evaluation PreclinicalAntibodies MonoclonalBone Marrow CellsSettore MED/08 - Anatomia Patologicamultiple myelomaDrug Delivery SystemsCell Line TumorHumanscomplementimmunotherapymieloma multiploPSGL-1ADCCComplement Activationmonoclonal antibodie
researchProduct

Quantitative analysis of opsonophagocytosis and of killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry

1991

We describe a simple, rapid, automated procedure for measuring opsonophagocytosis and killing of Candida albicans by human peripheral blood leukocytes. Yeast cells are labelled by allowing uptake and cleavage of membrane-permeable bis-carboxyethyl-carboxyfluorescein pentaacetoxymethylester to its membrane-impermeable fluorescent derivative bis-carboxyethyl-carboxyfluorescein. The yeast cells are added to cell-rich plasma obtained after dextran sedimentation of erythrocytes. Opsonophagocytosis and killing are quantified by using automated fluorescent cell analysis, and the following parameters can be obtained: (i) relative percentage of phagocytes that participate in opsonophagocytosis, (ii)…

Cytotoxicity ImmunologicMicrobiology (medical)Phagocytemedicine.drug_classPhagocytosisIn Vitro TechniquesMonoclonal antibodyMicrobiologyFlow cytometryPhagocytosisCandida albicansLeukocytesmedicineHumansCandida albicansPhagocytesbiologymedicine.diagnostic_testOpsonin ProteinsFlow Cytometrybiology.organism_classificationMolecular biologyYeastCorpus albicansAntibody opsonizationmedicine.anatomical_structureEvaluation Studies as TopicResearch ArticleJournal of Clinical Microbiology
researchProduct

Wood-inhabiting fungal responses to forest naturalness vary among morpho-groups

2021

The general negative impact of forestry on wood-inhabiting fungal diversity is well recognized, yet the effect of forest naturalness is poorly disentangled among different fungal groups inhabiting dead wood of different tree species. We studied the relationship between forest naturalness, log characteristics and diversity of different fungal morpho-groups inhabiting large decaying logs of similar quality in spruce dominated boreal forests. We sampled all non-lichenized fruitbodies from birch, spruce, pine and aspen in 12 semi-natural forest sites of varying level of naturalness. The overall fungal community composition was mostly determined by host tree species. However, when assessing the …

DECIDUOUS FORESTSnature sitesspeciesnatural forestsfungal responsespuulajitREGIONAL BIOLOGICAL RECORDSlogging sitestree speciespinespopulaatiotCentral FinlandASCOMYCETOID TAXAFinlandsienitiedekoostumusQforestryReliöyhteisötmetsätluonnontilalahottajasienetekologiaboreaalinen vyöhykedecayed woodforest naturalness1181 Ecology evolutionary biologyboreal zoneMedicineecologyDEAD WOODsienetwoodtalousmetsätScienceCONSERVATIONluonnonmetsätSPRUCEArticlediversitymetsätaloussuojelualueetmonimuotoisuuslajitlahopuutforestsbiodiversiteettiSIZEPATTERNSmycologyfunginaturalnessmorpho-groupspineScientific Reports
researchProduct

Robots that look like humans: A brief look into humanoid robotics

2018

This article provides a brief overview of the technology of humanoid robots. First, historical development and hardware progress are presented mainly on human-size full-body biped humanoid robots, together with progress in pattern generation of biped locomotion. Then, «whole-body motion» – coordinating leg and arm movements to fully leverage humanoids’ high degrees of freedom – is presented, followed by its applications in fields such as device evaluation and large-scale assembly. Upper-body humanoids with a mobile base, which are mainly utilized for research on human-robot interaction and cognitive robotics, are also introduced before addressing current issues and perspectives.

DEVICE EVALUATIONMultidisciplinaryHistory and Philosophy of ScienceHuman–computer interactionComputer scienceRobotDegrees of freedom (mechanics)Pattern generationCognitive roboticsMotion (physics)Humanoid robotMètode Revista de difusió de la investigació
researchProduct

Entrepreneurship Training and Self-Employment among University Graduates

2012

In economies characterized by low labor demand and high rates of youth unemployment, entrepreneurship training has the potential to enable youth to gain skills and create their own jobs. This paper presents experimental evidence on a new entrepreneurship track that provides business training and personalized coaching to university students in Tunisia. Undergraduates in the final year of licence appliquee were given the opportunity to graduate with a business plan instead of following the standard curriculum. This paper relies on randomized assignment of the entrepreneurship track to identify impacts on labor market outcomes one year after graduation. The analysis finds that the entrepreneur…

DISADVANTAGED YOUTHEMPLOYMENT PROGRAMSUNIVERSITY STUDENTSFINANCIAL ANALYSISEXAMSENTREPRENEURSHIP SUPPORTPRIVATE SECTOR JOBSCLASSROOMEMPLOYMENT OPPORTUNITIESEMPLOYMENTACTIVE LABOR MARKETHIGH UNEMPLOYMENTPERSONALITYPRESENT EVIDENCEINFORMATION ABOUT CREDITENTREPRENEURIAL ACTIVITIES[ SHS.EDU ] Humanities and Social Sciences/EducationWORKERSENROLLMENT RATESBUSINESS OWNERSWAGE SUBSIDYEMPLOYMENT OUTCOMESGRADUATION RATEOCCUPATIONSMENTAL HEALTHPUBLIC SECTOR JOBSLABOR MARKET OUTCOMESYOUTH TRAININGCOLLEGE GRADUATEINTERVENTIONSEARNINGSREADINGSKILLED WORKERSBUSINESS TRAININGSALARIED EMPLOYMENT[SHS.EDU]Humanities and Social Sciences/EducationCOMPETENCIESLOCAL EMPLOYMENT OFFICEVENTURE CAPITAL FIRMWORKERUNEMPLOYEDUNIVERSITY PROFESSORSPLAYINGHIGHER EDUCATIONJOB SEARCHLITERACYRECOGNITIONENTREPRENEURSHIP TRAININGSTHINKINGBUSINESS SURVIVALSURVIVAL RATESYOUTH UNEMPLOYMENTEMPLOYABILITYLABOR DEMANDUNEMPLOYMENT SPELLSATTRITIONMINIMUM WAGESKILLS DEVELOPMENTPROFITABILITYFINANCIAL LITERACYPRODUCTIVITY GROWTHENTREPRENEURSPREVIOUS SECTIONGROSS ENROLLMENTSPORTSUNIVERSITY DEGREEEMPLOYMENT STATUSLABOUREXCLUSIONYOUTH UNEMPLOYMENT RATESTART-UPHUMAN DEVELOPMENTNEW BUSINESSESYOUTH EMPLOYMENTPOST-SECONDARY EDUCATIONACADEMIC YEARACCESS TO INFORMATIONUNEMPLOYMENT RATEEMPLOYMENT RATEMINISTRIES OF EDUCATIONBUSINESS PLANLABOR ECONOMICSTELECOMMUNICATIONSJOB SATISFACTIONWAGE SUBSIDY PROGRAMSSOCIAL NETWORKYOUNG WORKERSGROSS ENROLLMENT RATESLOANProgram evaluationPRIVATE SECTOR WAGEMICROFINANCEWAGE SUBSIDIESDEVELOPMENT BANKINDIVIDUAL ENTREPRENEURSHIPComputingMilieux_THECOMPUTINGPROFESSIONGRADUATION REQUIREMENTSPRIVATE SECTOR JOBPUBLIC EMPLOYMENTATTENTIONSALARIED WORKERSKILLS TRAININGSTART-UP CAPITALLEADERSHIPGENDERADMINISTRATIVE RECORDSON-THE-JOB TRAININGFEMALE ENTERPRISEENTREPRENEURSHIP DEVELOPMENTLOCAL EMPLOYMENT OFFICESLABOR FORCE SURVEYPRELIMINARY EVIDENCEEMPLOYERSGRADUATES WITH SKILLSENTREPRENEURFAMILIESTRAINING PROGRAMSEMPLOYMENT OFFICEYOUTH UNEMPLOYMENT RATESCLASSROOM TRAININGJOB OPPORTUNITIESFIRM SIZEUNDERGRADUATESJOBSCURRICULUMUNIVERSITY GRADUATESEMPLOYMENT PROGRAMPUBLIC SECTOR JOBTRAINING PROGRAMMINISTRY OF EDUCATIONTRAINING COURSEUNEMPLOYED YOUTHTRAINING COMPONENTCOMMUNITY COLLEGEENTREPRENEURIAL ACTIVITYEMPLOYMENT IMPACTSSelf-employmentPREVIOUS STUDIESSELF-EMPLOYMENTLACK OF ACCESSLABOR MARKETELIGIBLE STUDENTSSOCIAL COHESIONVOCATIONAL TRAINING PROGRAMSCONTROL GROUPSTECHNICAL KNOWLEDGETERTIARY EDUCATIONGROWTH OPPORTUNITIESSOCIAL SECURITYLITERATURELABOR MARKET EXPERIENCETRAINING PARTICIPANTSECONOMIC CHARACTERISTICSPERSONALITY TRAITSEntrepreneurship trainingDEVELOPMENT CENTERCREDIT CONSTRAINTSEMPLOYMENT POLICIESBUSINESS PLANSOPEN ACCESSTRAINING CONTENTMICRO ENTERPRISESPAPERSWAGE EMPLOYMENTACTIVE LABOR MARKET PROGRAMSJOB OFFERSUBSTITUTION EFFECTPRIVATE SECTORCREDIT ACCESSBehavioral skill[SHS.EDU] Humanities and Social Sciences/EducationHOUSEHOLD INCOMEMICROFINANCE INSTITUTIONSYOUTH TRAINING PROGRAMTEACHINGLEARNINGACCESS TO CREDITPSYCHOLOGYACHIEVEMENTINTERNATIONAL BANKVENTURE CAPITALACCESS TO JOBSUNIVERSITIESPROGRAM BENEFICIARIESSoft skillMOTIVATIONRECALLCREDIT APPLICATIONSLABOR FORCEFINANCIAL SUPPORTBUSINESS NETWORKSMICRO FINANCEVOCATIONAL TRAININGENTREPRENEURIAL SKILLSYouth employmentENTREPRENEURSHIP TRAININGLACK OF INFORMATIONACTIVE LABOR
researchProduct

Búsqueda de compuestos con potencial terapéutico para la enfermedad de Parkinson y estudio de la relación entre la enfermedad de Parkinson y la Diabe…

2022

La enfermedad de Parkinson (EP) es la segunda enfermedad neurodegenerativa más frecuente. Actualmente, la EP no tiene cura, y las terapias existentes solo son capaces de tratar los síntomas de esta enfermedad, pero no de ralentizar o de parar su progresión. Con el objetivo de descubrir nuevos fármacos que pudieran ser útiles para tratar esta enfermedad, hemos realizado un rastreo a gran escala, evaluando los compuestos incluidos en la quimioteca Prestwick (1120 compuestos). Para ello, estudiamos el efecto de estos compuestos sobre la actividad motora en un modelo de la EP en Drosophila basado en la mutación del gen DJ-1beta (ortólogo del gen humano DJ-1, cuya mutación es causante de casos f…

DJ-1:CIENCIAS DE LA VIDA::Biología humana ::Genética humana [UNESCO]:QUÍMICA::Bioquímica ::Biología molecular [UNESCO]:CIENCIAS DE LA VIDA::Neurociencias [UNESCO]drosophilaSH-SY5YUNESCO::QUÍMICA::Bioquímica ::Biología molecularenfermedad de parkinsondiabetes mellitusUNESCO::CIENCIAS DE LA VIDA::Biología humana ::Genética humanaUNESCO::CIENCIAS DE LA VIDA::Neurociencias:CIENCIAS MÉDICAS ::Farmacología ::Evaluación de medicamentos [UNESCO]búsqueda de tratamientosUNESCO::CIENCIAS MÉDICAS ::Farmacología ::Evaluación de medicamentos
researchProduct

Genotoxicity of the fungicide dichlofluanid in seven assays

1991

Seven different endpoints for detection of genotoxicity have been used to demonstrate the DNA-altering properties of Dichlofluanid, a fungicide commonly used in viticulture pest control. Each endpoint (DNA synthesis inhibition test, alkaline viscosimetry, umu-test, alkaline filter elution, FADU-test, 32P-postlabeling, and electron microscopy) shows clear evidence of genotoxicity. These data indicate that application of the fungicide dichlofluanid may be mutagenic and/or carcinogenic for exposed humans.

DNA ReplicationSalmonella typhimuriumDNA AlterationEpidemiologyHealth Toxicology and MutagenesisDichlofluanidmedicine.disease_causeCell LineMicechemistry.chemical_compoundmedicineAnimalsHumansBioassayGenetics (clinical)CaptanCarcinogenAniline CompoundsMutagenicity TestsFishesDNAPesticideFungicides IndustrialFungicideBiochemistrychemistryGenotoxicityDNA DamageHeLa CellsMutagensEnvironmental and Molecular Mutagenesis
researchProduct